ZA972757B - Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis. - Google Patents
Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis.Info
- Publication number
- ZA972757B ZA972757B ZA9702757A ZA972757A ZA972757B ZA 972757 B ZA972757 B ZA 972757B ZA 9702757 A ZA9702757 A ZA 9702757A ZA 972757 A ZA972757 A ZA 972757A ZA 972757 B ZA972757 B ZA 972757B
- Authority
- ZA
- South Africa
- Prior art keywords
- antigen
- gingivalis
- amino acid
- acid sequence
- internal amino
- Prior art date
Links
- 241000605862 Porphyromonas gingivalis Species 0.000 title abstract 7
- 238000003745 diagnosis Methods 0.000 title 1
- 201000001245 periodontitis Diseases 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 8
- 102000036639 antigens Human genes 0.000 abstract 8
- 108091007433 antigens Proteins 0.000 abstract 8
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 4
- 101710145634 Antigen 1 Proteins 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 2
- 101710135378 pH 6 antigen Proteins 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56955—Bacteria involved in periodontal diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Birds (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPN9012A AUPN901296A0 (en) | 1996-03-29 | 1996-03-29 | Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA972757B true ZA972757B (en) | 1998-01-30 |
Family
ID=3793326
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9702757A ZA972757B (en) | 1996-03-29 | 1997-04-01 | Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis. |
Country Status (12)
Country | Link |
---|---|
US (1) | US6528038B1 (xx) |
EP (1) | EP0954529B1 (xx) |
JP (1) | JP4358909B2 (xx) |
KR (1) | KR100527070B1 (xx) |
AT (1) | ATE398137T1 (xx) |
AU (1) | AUPN901296A0 (xx) |
CA (1) | CA2249746C (xx) |
DE (1) | DE69738770D1 (xx) |
DK (1) | DK0954529T3 (xx) |
NZ (1) | NZ331557A (xx) |
WO (1) | WO1997036923A1 (xx) |
ZA (1) | ZA972757B (xx) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPO652897A0 (en) | 1997-04-30 | 1997-05-29 | University Of Melbourne, The | Synthetic peptide constructs for the diagnosis and treatment of periodontitis |
JP2001526035A (ja) * | 1997-12-10 | 2001-12-18 | シーエスエル、リミテッド | Porphorymonasgingivalisポリペプチドおよびヌクレオチド |
US8129500B2 (en) * | 1997-12-10 | 2012-03-06 | Csl Limited | Porphyromonas gingivalis polypeptides and nucleotides |
AUPP494798A0 (en) | 1998-07-29 | 1998-08-20 | Pacific Biolink Pty Limited | Protective protein formulation |
AUPP893999A0 (en) * | 1999-03-01 | 1999-03-25 | Csl Limited | Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
EP1292332B1 (en) * | 2000-06-16 | 2007-02-21 | Baylor Research Institute | ADJUVANTS AND PROCESSES TO INDUCE A Th2 IMMUNE RESPONSE |
JP5469785B2 (ja) * | 2004-02-06 | 2014-04-16 | 有限会社 ミクロデント | ポルフィロモナスジンジバリス試薬 |
US7838259B2 (en) | 2005-02-01 | 2010-11-23 | University Of Florida Research Foundation | Genes of Porphyromonas gingivalis W83 involved in invasion of human cells |
US20100092471A1 (en) * | 2006-06-27 | 2010-04-15 | Oral Health Australia Pty Ltd | Porphyromonas Gingivalis Polypeptides Useful in the Prevention of Periodontal Disease |
AU2008274906B2 (en) * | 2007-07-12 | 2013-11-07 | Oral Health Australia Pty Ltd | Biofilm treatment |
CA2693717A1 (en) | 2007-07-12 | 2009-01-15 | Stuart Geoffrey Dashper | Immunology treatment for biofilms |
KR101721904B1 (ko) | 2008-08-29 | 2017-04-11 | 오럴 헬스 오스트레일리아 피티와이 엘티디 | P.진지발리스 감염의 예방, 치료 및 진단 |
US9366673B2 (en) * | 2009-08-02 | 2016-06-14 | Sanofi Pasteur Limited | Porphyromonas gingivalis polypeptides |
US8140041B2 (en) * | 2009-08-27 | 2012-03-20 | Mediatek Inc. | Tunable capacitive device with linearization technique employed therein |
KR102037969B1 (ko) * | 2019-07-25 | 2019-10-29 | 주식회사 하이센스바이오 | 신규한 펩타이드 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60142915A (ja) * | 1983-12-28 | 1985-07-29 | Lion Corp | 口腔用組成物 |
CA1282691C (en) * | 1986-02-26 | 1991-04-09 | Robert Joseph Genco | Monoclonal antibodies useful in the identification of microorganisms causing periodontal disease |
US5830710A (en) * | 1988-09-08 | 1998-11-03 | University Of Florida | Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
US5399484A (en) * | 1991-10-08 | 1995-03-21 | Eastman Kodak Company | Use of blocking protein with high pH extraction in method to determine a microorganism associated with periodontal disease and kit useful therefor |
US5523390A (en) * | 1993-09-10 | 1996-06-04 | University Of Georgia Research Foundation, Inc. | Porphyromonas gingivalis arginine-specific proteinase |
JPH0797395A (ja) * | 1993-09-28 | 1995-04-11 | Kyowa Medex Co Ltd | ポルフイロモナス・ジンジバリス線毛蛋白質の配列を含有するペプチド類及びその用途 |
EP0726314A4 (en) * | 1993-10-08 | 1998-04-22 | Lion Corp | FIMBRILLIN PROTEIN FROM -i (PORPHYROMONAS GINGIVALIS) |
WO1995026404A1 (fr) * | 1994-03-29 | 1995-10-05 | Kyowa Hakko Kogyo Co., Ltd. | Gene de polypeptide de surface |
-
1996
- 1996-03-29 AU AUPN9012A patent/AUPN901296A0/en not_active Abandoned
-
1997
- 1997-04-01 KR KR1019980706858A patent/KR100527070B1/ko not_active IP Right Cessation
- 1997-04-01 CA CA2249746A patent/CA2249746C/en not_active Expired - Fee Related
- 1997-04-01 EP EP97913999A patent/EP0954529B1/en not_active Expired - Lifetime
- 1997-04-01 DE DE69738770T patent/DE69738770D1/de not_active Expired - Lifetime
- 1997-04-01 WO PCT/AU1997/000212 patent/WO1997036923A1/en active IP Right Grant
- 1997-04-01 US US09/101,307 patent/US6528038B1/en not_active Expired - Lifetime
- 1997-04-01 ZA ZA9702757A patent/ZA972757B/xx unknown
- 1997-04-01 JP JP53475397A patent/JP4358909B2/ja not_active Expired - Fee Related
- 1997-04-01 DK DK97913999T patent/DK0954529T3/da active
- 1997-04-01 NZ NZ331557A patent/NZ331557A/xx not_active IP Right Cessation
- 1997-04-01 AT AT97913999T patent/ATE398137T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0954529A4 (en) | 2003-02-05 |
KR19990087436A (ko) | 1999-12-27 |
AUPN901296A0 (en) | 1996-04-26 |
DK0954529T3 (da) | 2008-09-29 |
DE69738770D1 (de) | 2008-07-24 |
EP0954529A1 (en) | 1999-11-10 |
NZ331557A (en) | 1999-11-29 |
EP0954529B1 (en) | 2008-06-11 |
KR100527070B1 (ko) | 2006-06-29 |
CA2249746C (en) | 2012-06-12 |
ATE398137T1 (de) | 2008-07-15 |
JP4358909B2 (ja) | 2009-11-04 |
CA2249746A1 (en) | 1997-10-09 |
WO1997036923A1 (en) | 1997-10-09 |
JP2001501808A (ja) | 2001-02-13 |
US6528038B1 (en) | 2003-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA972757B (en) | Porphyromonas gingivalis antigents for the diagnosis and treatment of periodontitis. | |
AU594488B2 (en) | Agents for the treatment of arthroses | |
EP0784469A4 (en) | AGENTS FOR THE ADMINISTRATION OF ANTIGENS | |
MY134811A (en) | A vaccine composition comprising an antigen, a saponin and a sterol | |
PL332742A1 (en) | Transformed human antibody against hm 1.24 | |
GR3029791T3 (en) | Improved immunogenic compositions against human gastrin 17 | |
HUT63063A (en) | Process for producing antibodies against cd44 cell surface glycoprotein and immunosuppressant pharmaceutical compositions comprising same | |
CA2288234A1 (en) | Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis | |
HK1016017A1 (en) | Gonococcal anti-idiotypic antibodies and methods and compositions using them | |
GB9501826D0 (en) | Polypeptide fragments | |
EP0770624A3 (en) | Peptide capable of inducing immune response to human gastric cancer and agent containing it for preventing or treating human gastric cancer | |
CA2137280A1 (fr) | Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications | |
PL313322A1 (en) | Method of obtaining 9-(2-hydroxy)etyhoxymethylquanine | |
BG102890A (en) | Vaccine for mammals of the feline family containing chlamydia prittaci, and a method for its preparation | |
WO1997039029A3 (en) | An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof | |
UA42741C2 (uk) | Пептид маститної вакцини (варіанти), пептид складного антигенного представлення (варіанти), фармацевтична композиція (варіанти) | |
WO2004033483A3 (en) | Liposomal system and method of using same | |
AU2548597A (en) | Antibodies against avirulence/pathogenicity proteins of plant pathogens | |
IL117151A0 (en) | Novel antigen | |
AU653332B2 (en) | Synthetic peptides which contain sequences from factor VIIa, and the use thereof | |
MX9702895A (es) | Composiciones para el suministro de antigenos. | |
DE69012328D1 (de) | Srif-verwandte peptide und deren verwendungen. |